Collaborations

Collaborations

To advance our mission of providing clinical diagnostics to improve patient outcomes SpeeDx collaborate with partners across the diagnostic space. PlexPCR® technology has helped transform infectious disease diagnostics, as well as significantly impacting cancer diagnosis and treatment.

Biocartis

Significant improvements in the diagnosis and treatment of cancer have occurred through a licensing partnership with Biocartis. PlexPCR® drives the market-leading multiplex capability in the Biocartis Idylla platform.

  • Using PlexZyme® and PlexPrime® PCR in the testing cartridge, Idylla can detect over 50 gene mutations in a tumour biopsy (FFPE, blood or plasma).
  • PlexPCR® provides high specificity and sensitivity (Limit of Detection of < 1% and as low as 0.01%), ideal for liquid biopsy testing where DNA material is limited.
Biocartis Idylla instrument
Scientist using MG FleXible product

Cepheid

SpeeDx partnered with Cepheid as a trusted reagent manufacturer (TRM) under their FleXible Cartridge program, aimed at accelerating menu expansion on the Cepheid GeneXpert systems.

The first test, ResistancePlus® MG FleXible, launched October 2019, detecting the sexually transmitted infection (STI) Mycoplasma genitalium (Mgen) and markers associated with azithromycin resistance.

News:

GSK

SpeeDx signed a collaboration agreement with GSK to provide tests and custom test development to support antibiotic clinical trials and new product development.

News:

GSK logo on building

LabCorp

SpeeDx and LabCorp are working together to develop and introduce new tests with the promise to help improve patient care, focusing on women’s health and infectious diseases.

News:

Roche

SpeeDx partnered with Roche, a global pioneer in pharmaceuticals and diagnostics, to expand access to infectious disease and antibiotic resistance tests and technology. Under the terms of the agreement, Roche has non-exclusive access to SpeeDx existing tests and technology for the management of antibiotic resistance in STIs, to quickly bring new products to a broader group of patients around the world.

News:

View Products from Roche:

Roche logo
Learn more about our collaborations & partnerships